Letter by Jin-shan and Xue-bin Regarding Article, “physiology of Angina and Its Alleviation with Nitroglycerin: Insights from Invasive Catheter Laboratory Measurements During Exercise”

He Jin-shan,Li Xue-bin
DOI: https://doi.org/10.1161/circulationaha.117.031098
IF: 37.8
2018-01-01
Circulation
Abstract:We read with great interest the article presented by Asrress and colleagues 1 about the physiology of angina and its alleviation with nitroglycerin (NTG), which characterizes intracoronary physiological behavior of coronary stenosis during exercise before and after NTG and explains the physiological consequences directly related to angina relief (reducing myocardial oxygen demand and increasing supply).We have 2 questions about this article.First, β-blocker, calcium channel antagonist, and NTG are common drugs used to alleviate angina.Now that we have a clear understanding of NTG's effect on angina, can we study the physiological influence of the other 2 kinds of drugs in the same way?If so, we would have a better understanding of their difference in angina relief and could prescribe them appropriately for different patients.Second, all the patients' angina in the study group is alleviated by NTG, which is different from outcomes in real clinical practice.Patients with unstable symptoms, previous myocardial infarction, ejection fraction <50%, known left main stem disease, and severe multivessel coronary artery disease are all excluded.In the future, can we include these patients in the study?Cases with angina that cannot be relieved by NTG will show up and help us understand the physiological mechanism of NTG-resistant angina.Is it because of failure in reducing myocardial oxygen demand?Or increasing supply?We will manage patients with angina better with this information, especially those who are resistant to common therapy.
What problem does this paper attempt to address?